Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons dr. M.H.M. Oonk

Publicaties

FIGO 2021 depth of invasion measurement and missed lymph node involvement in microinvasive vulvar squamous cell carcinoma: Is the gain worth the cost?

From evidence to practice: Real-world implementation of ESGO 2023 guidelines for adjuvant radiotherapy in vulvar cancer

APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma-a multicenter, single-arm, phase II, clinical proof-of-concept study

Comprehensive management of vulvovaginal cancers

Molecular image–guided surgery in gynaecological cancer: where do we stand?

Prognostic value of HPV-PCR, p16 and p53 immunohistochemical status on local recurrence rate and survival in patients with vulvar squamous cell carcinoma

Update on the Sentinel Node Procedure in Vulvar Cancer

European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023

Incidence of inguinofemoral lymph node metastases at the first local recurrence of vulvar cancer: a Dutch nationwide study

Phase II activity trial of high-dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: GROningen INternational Study on Sentinel nodes in Vulvar cancer III (GROINSS-V III/NRG-GY024)

Pers/media

Podcast “Vulvacarcinoom, met Maaike Oonk” for “Verlossende Woorden” (2025)

Podcast “ESGO Vulvar Cancer Guidelines 2023 with Maaike Oonk”

Webinar for “Olijf” on vulvar cancer treatment and consequences

Nieuwe behandeling voor vulvakanker nabij

UMCG: “Resultaten nieuwe behandeling vulvakanker veelbelovend”

UMCG-onderzoekers ontwikkelen nieuwe behandeling voor vulvakanker

Pervers ideaalbeeld niet normaliseren

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijnSDG 9 – Industrie, innovatie en infrastructuurSDG 17 - Partnerschap om de doelen te bereiken

Meer informatie over de Sustainable Development Goals.